Biology Scientists (In Vivo) : 2654-1

At the dawn of the new millennium, a unique information technology company was born: HCL Technologies. As narrated in the video below, HCL Technologies has demonstrated remarkable growth through the recent economic downturn, emerging as one of only eight 21st century listed technology companies in the world to cross $1bn in Net Profit, $6bn in Revenue and $15bn in Market Capitalization.

The contingent worker will be working under the supervision of Oncology In Vivo Pharmacologists and will be required to adhere to the relevant established Animal Use Protocols and SOPs for PDX work at Pharmaceutical.

Scope of work The contingent worker will be responsible for mouse cancer model development.

This work will primarily be the establishment and maintenance of patient-derived cancer xenografts but could also include development of cell line xenografts.

This work requires sterile technique and attention to detail.

Work is conducted both in an animal facility (vivarium) as well as in biosafety cabinets (laminar flow hoods).

The worker will also be required to participate in all of the preparation steps necessary for animal studies: surgical tool preparation, tool sterilization, and animal shaving and preparation.

Required skills / background -

The worker should have a minimum 1-3 years experience working with mice, preferably immune deficient mice.

The workers should also have experience in small animal surgery and sterile techniques.

The workers should preferably have knowledge of cancer research experimental designs and methods.

Experience with dosing mice would be useful but is not a strict requirement.

Additional Skills:

Mouse handling (preferable immune deficient), mouse surgery, sterile technique, tissue culture, and database maintenance

Level candidate we are seeking (i.e. 1-3yrs = Base/Entry; 4-7yrs = Intermediate; 7+ = Advanced) Entry or intermediate dependent upon experience and skill sets

BS

Best Regards,

Akriti Gupta

(973) 967-3409

Morristown, NJ 07960